JPWO2020123925A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020123925A5 JPWO2020123925A5 JP2021533779A JP2021533779A JPWO2020123925A5 JP WO2020123925 A5 JPWO2020123925 A5 JP WO2020123925A5 JP 2021533779 A JP2021533779 A JP 2021533779A JP 2021533779 A JP2021533779 A JP 2021533779A JP WO2020123925 A5 JPWO2020123925 A5 JP WO2020123925A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- pharmaceutically acceptable
- compound
- tautomer
- solvate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862780066P | 2018-12-14 | 2018-12-14 | |
| US62/780,066 | 2018-12-14 | ||
| PCT/US2019/066201 WO2020123925A1 (en) | 2018-12-14 | 2019-12-13 | Pyrazolopyridine inhibitors of c-jun-n-terminal kinases and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022513846A JP2022513846A (ja) | 2022-02-09 |
| JPWO2020123925A5 true JPWO2020123925A5 (enrdf_load_stackoverflow) | 2022-12-21 |
| JP7642540B2 JP7642540B2 (ja) | 2025-03-10 |
Family
ID=71077020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021533779A Active JP7642540B2 (ja) | 2018-12-14 | 2019-12-13 | Ｃ－ｊｕｎ－ｎ末キナーゼのピラゾロピリジンインヒビターおよびそれらの使用 |
Country Status (7)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011090738A2 (en) | 2009-12-29 | 2011-07-28 | Dana-Farber Cancer Institute, Inc. | Type ii raf kinase inhibitors |
| CA2972239A1 (en) | 2014-12-23 | 2016-06-30 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinase 7 (cdk7) |
| US10550121B2 (en) | 2015-03-27 | 2020-02-04 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinases |
| AU2017363307B2 (en) | 2016-11-22 | 2021-07-29 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinase 12 (CDK12) and uses thereof |
| CN113557017B (zh) | 2018-12-28 | 2024-11-29 | 丹娜-法伯癌症研究院 | 细胞周期蛋白依赖性激酶7的抑制剂及其用途 |
| AU2020315640A1 (en) * | 2019-07-17 | 2022-03-03 | Kinnate Biopharma Inc. | Inhibitors of cyclin-dependent kinases |
| US12084453B2 (en) | 2021-12-10 | 2024-09-10 | Incyte Corporation | Bicyclic amines as CDK12 inhibitors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2013218A2 (en) | 2006-04-17 | 2009-01-14 | Arqule, Inc. | Raf inhibitors and their uses |
| US20110039873A1 (en) | 2009-06-08 | 2011-02-17 | Gaeta Federico C A | SUBSTITUTED PYRAZOLO[1,5-a] PYRIDINE COMPOUNDS HAVING MULTI-TARGET ACTIVITY |
| BR112013011520A2 (pt) * | 2010-11-19 | 2019-09-24 | Hoffmann La Roche | pirazolo piridinas e pirazolo piridinas e seu uso como inibidores de tyk2 |
| EP3569598A1 (en) * | 2011-11-17 | 2019-11-20 | Dana Farber Cancer Institute, Inc. | Inhibitors of c-jun-n-terminal kinase (jnk) |
| US10112927B2 (en) * | 2012-10-18 | 2018-10-30 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinase 7 (CDK7) |
| TWI621618B (zh) * | 2013-03-13 | 2018-04-21 | 比利時商健生藥品公司 | 經取代２－氮雜雙環類及其作為食慾素受體調控劑之用途 |
| ES2676734T3 (es) | 2013-10-18 | 2018-07-24 | Syros Pharmaceuticals, Inc. | Compuestos heteroatómicos útiles para el tratamiento de enfermedades proliferativas |
| WO2015058140A1 (en) | 2013-10-18 | 2015-04-23 | Dana-Farber Cancer Institute, Inc. | Polycyclic inhibitors of cyclin-dependent kinase 7 (cdk7) |
-
2019
- 2019-12-13 CN CN201980080949.8A patent/CN113164477A/zh active Pending
- 2019-12-13 WO PCT/US2019/066201 patent/WO2020123925A1/en unknown
- 2019-12-13 AU AU2019395255A patent/AU2019395255B2/en active Active
- 2019-12-13 US US17/413,299 patent/US20220073512A1/en active Pending
- 2019-12-13 CA CA3115126A patent/CA3115126A1/en active Pending
- 2019-12-13 JP JP2021533779A patent/JP7642540B2/ja active Active
- 2019-12-13 EP EP19894946.3A patent/EP3893879A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU766193B2 (en) | 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents | |
| JP5576485B2 (ja) | 新生物疾患又は自己免疫疾患を処置するためのプロドラッグとしてのフラザノベンゾイミダゾール | |
| EP2137158A1 (en) | Small molecule inhibitors of protein arginine methyltransferases (prmts) | |
| JP2018522866A5 (enrdf_load_stackoverflow) | ||
| ES2989149T3 (es) | Inhibidores de HAT p300/CBP | |
| JP2018515434A5 (enrdf_load_stackoverflow) | ||
| JP2018522867A5 (enrdf_load_stackoverflow) | ||
| WO1999019303A1 (fr) | Derives de pyrazole | |
| JP2021521120A (ja) | サイクリン依存性キナーゼの選択的インヒビターとしてのピラゾロ−トリアジン誘導体および／またはピラゾロ−ピリミジン誘導体 | |
| NZ259114A (en) | Pyrazolopyrimidines and pharmaceutical compositions thereof | |
| BR112013026137B1 (pt) | pirimidinil-pirróis substituídos ativos como inibidores da quinase | |
| JP2010513283A5 (enrdf_load_stackoverflow) | ||
| AU2015335783B2 (en) | Tricyclic atropisomer compounds | |
| AU2011204370B2 (en) | Hedgehog inhibitors | |
| MD3692039T2 (ro) | Enantiomerii tiazolilor substituiți ca compuși antivirali | |
| EA022473B1 (ru) | Производные 5-циано-2-амино-1,3-тиазола в качестве антагонистов аденозинового арецептора | |
| WO2022127199A1 (zh) | 一类抑制rna解旋酶dhx33的多环化合物及其应用 | |
| IL263793B1 (en) | Compounds and preparations for the treatment of cancer | |
| CA2842360A1 (en) | Targeting gli proteins in human cancer by small molecules | |
| JPWO2020123925A5 (enrdf_load_stackoverflow) | ||
| CA2830148C (en) | Novel furanone derivatives | |
| JP4385414B2 (ja) | アミド若しくはアミン誘導体 | |
| JP2008519815A5 (enrdf_load_stackoverflow) | ||
| CN112759588B (zh) | 苯并五元杂环胺类衍生物及其用途 | |
| TWI715156B (zh) | 苯并咪唑化合物及其用於治療阿茲海默症或亨丁頓氏症之用途 |